Consensus Emerging On Need To Mesh CER And Personalized Medicine
This article was originally published in The Gray Sheet
Executive Summary
A distinct consensus is emerging in Washington that comparative effectiveness research needs to be done in a way that does not threaten the progress of personalized medicine